Colchicine in Patients Undergoing Coronary Artery Bypass Grafting After Acute Coronary Syndrome: an Open-label Randomized Trial.

Patients with acute coronary syndrome, who meetcriteria for surgical myocardial revascularization, will be selected andrandomize, with drug addition, in the intervention group, within amaximum of 24 hours after randomization and maintained for up to 30 daysafter coronary artery bypass grafting. Addiction Research - Drug Abuse Staff editors report on the newly launched clinicaltrial, NCT05726019, which has the following summary description: "Thepresent study seeks to evaluate the effectiveness of the use ofperioperative colchicine with regard to operative complications, inpatients with acute coronary syndrome and indication for cardiacpost-surgical revascularization. [Extracted from the article]